Stay updated on EXHALE-1 Biomarker Study in Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the EXHALE-1 Biomarker Study in Eosinophilic Asthma Clinical Trial page.

Latest updates to the EXHALE-1 Biomarker Study in Eosinophilic Asthma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site version label changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe study record now presents details of the dexpramipexole dose-ranging trial, including its design, eligibility criteria, treatment arms, outcomes, results-related dates, and study locations. It also includes supporting study documents and related information.SummaryDifference72%

- Check19 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedA banner about NIH’s website terminology transition was added, and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe deletions remove the 403 Forbidden content and the Home link from the study record view, indicating that an access error was resolved and the standard navigation is restored.SummaryDifference0.5%

Stay in the know with updates to EXHALE-1 Biomarker Study in Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EXHALE-1 Biomarker Study in Eosinophilic Asthma Clinical Trial page.